1. Jung HR, Kim SJ, Ham SH, Cho JH, Lee YB, Cho HY: Simultaneous determination of puerarin and its active metabolite in human plasma by UPLC-MS/MS: application to a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Nov 15;971:64-71. doi: 10.1016/j.jchromb.2014.09.015. Epub 2014 Sep 22. [PubMed:25264914 ]
  2. Kim Y, Jeon JY, Kim EY, Lim CH, Jang HB, Kim MG: Pharmacokinetics and Safety of DW1029M, a Botanical Drug for the Treatment of Diabetic Nephropathy, Following Single Doses in Healthy Subjects. Clin Pharmacol Drug Dev. 2017 Sep;6(5):499-507. doi: 10.1002/cpdd.343. Epub 2017 Mar 16. [PubMed:28301092 ]
  3. Lee SY, Jeong JH, Kim BN, Park SJ, Park YC, Lee GY: LC-MS/MS analysis of puerarin and 18beta-glycyrrhetinic acid in human plasma after oral administration of Samso-eum and its application to pharmacokinetic study. Biomed Chromatogr. 2020 Apr;34(4):e4774. doi: 10.1002/bmc.4774. Epub 2020 Jan 23. [PubMed:31813157 ]
  4. Penetar DM, Teter CJ, Ma Z, Tracy M, Lee DY, Lukas SE: Pharmacokinetic profile of the isoflavone puerarin after acute and repeated administration of a novel kudzu extract to human volunteers. J Altern Complement Med. 2006 Jul-Aug;12(6):543-8. doi: 10.1089/acm.2006.12.543. [PubMed:16884345 ]
  5. Qin F, Huang X, Zhang HM, Ren P: Pharmacokinetic comparison of puerarin after oral administration of Jiawei-Xiaoyao-San to healthy volunteers and patients with functional dyspepsia: influence of disease state. J Pharm Pharmacol. 2009 Jan;61(1):125-9. doi: 10.1211/jpp/61.01.0018. [PubMed:19126307 ]
  6. Qu H. H., Wan F., Shan W. C., Wang X. Q., Cheng J. J., Kong H., Zhao Y., Wang Q. G.: Pharmacokinetic analysis of orally administered puerarin in human saliva using an indirect competition ELISA Analytical Methods. 2015 September 4;7(19):8335-8343.